Related Experiment Video
Updated: Jun 18, 2025

14:18
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.7K
Galectin-3 contributes to pathogenesis of IgA nephropathy
Yu-Ling Chou1, Hung-Lin Chen2, Bang-Gee Hsu3
1Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
Kidney International
|July 31, 2024
Summary
Galectin-3 (Gal-3) plays a key role in IgA nephropathy (IgAN) progression. Inhibiting Gal-3 improves kidney function and reduces inflammation in IgAN models, suggesting it as a potential therapeutic target.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- IgA nephropathy (IgAN) is a leading cause of kidney failure, but its molecular mechanisms are poorly understood.
- Galectin-3 (Gal-3), a galactoside-binding protein, has been implicated in various inflammatory conditions.
Purpose of the Study:
- To investigate the role of Gal-3 in the pathogenesis of IgA nephropathy (IgAN).
- To explore Gal-3 as a potential therapeutic target for IgAN.
Main Methods:
- Examined Gal-3 expression in IgAN patient kidneys and mouse models.
- Utilized Gal-3 knockout mice and a Gal-3 binding inhibitor in passive IgAN models.
- Assessed kidney function, pathology, immune cell differentiation, inflammasome activity, and autophagy.
Main Results:
- Gal-3 expression was significantly elevated in IgAN kidneys and correlated with disease severity.
- Gal-3 knockout mice showed reduced proteinuria, improved kidney function, and attenuated kidney pathology.
- Gal-3 inhibition decreased Th17 cell differentiation, suppressed NLRP3 inflammasome activation, enhanced autophagy, and reduced kidney inflammation and fibrosis.
Conclusions:
- Gal-3 is critically involved in IgAN pathogenesis.
- Targeting Gal-3 action, potentially with inhibitors, offers a promising new therapeutic strategy for IgAN treatment.
Related Concept Videos
Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
Gastritis-II: Pathophysiology
296
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
296
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Immunoglobulin-like Cell Adhesion Molecules
3.2K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.2K
Glucose Transporters
22.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.6K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K

